pr-inside.com
Print

Covidien to Present at Lazard Capital Markets Conference



2009-11-11 13:14:07 -

Covidien (NYSE: COV) will present at the Lazard Capital Markets 6th Annual Healthcare Conference in New York on Wednesday, November 18, 2009. Coleman Lannum, Vice President, Investor Relations, will represent the Company in a session scheduled at 11:30 a.m. ET.

A live audio webcast of the presentation can be accessed at Covidien’s Investor Relations website: investor.covidien.com : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Finv .. .

An

archived edition of the presentation will be available following the live webcast.

ABOUT COVIDIEN


Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2008 revenue of $10 billion, Covidien has more than 41,000 employees worldwide in 59 countries, and its products are sold in over 140 countries. Please visit www.covidien.com : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. to learn more about our business.


CovidienEric Kraus, 508-261-8305Senior Vice PresidentCorporate
Communications eric.kraus@covidien.com : mailto:eric.kraus@covidien.com orColeman

Lannum, CFAVice PresidentInvestor Relations508-452-4343 cole.lannum@covidien.com : mailto:cole.lannum@covidien.com orBruce
Farmer, 508-452-4372Vice PresidentPublic Relations bruce.farmer@covidien.com : mailto:bruce.farmer@covidien.com orBrian
Nameth, 508-452-4363DirectorInvestor Relations brian.nameth@covidien.com : mailto:brian.nameth@covidien.com

Author:
Hossam Abdel-Kader
e-mail
Web: http://www.pr-inside.com/
Telefon: +43 1 9582319




Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.